Skip to Content

4833M 15/500 (Actoplus Met 500 mg / 15 mg)

Generic Name: metformin/pioglitazone

Pill with imprint 4833M 15/500 is White, Elliptical / Oval and has been identified as Actoplus Met 500 mg / 15 mg. It is supplied by Takeda Pharmaceuticals America, Inc..

ActoPlus Met is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. ActoPlus Met 500 mg / 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 4833M 15/500

Actoplus met 500 mg / 15 mg 4833M 15/500
Actoplus met 500 mg / 15 mg 4833M 15/500 Front
Actoplus met 500 mg / 15 mg 4833M 15/500 Back
Actoplus met 500 mg / 15 mg 4833M 15/500

Actoplus Met

Generic Name:
metformin/pioglitazone
Imprint:
4833M 15/500
Strength:
500 mg / 15 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Takeda Pharmaceuticals America, Inc.

Labelers / Repackagers:

NDC CodeLabeler / Repackager
64764-0155 Takeda Pharmaceuticals U.S.A., Inc.
00093-5049 Teva Pharmaceuticals USA, Inc.
42291-0693 AvKare, Inc.
54868-5500 Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide